Description
The goal of this research inquiry is to provideinsights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with low dose computed tomography, which has taken place in officialrecommendations and clinical practice in the U.S. in recent years.
PI is Jiang Li, Ph.D., MPH. Co-PIs are Sukyung Chung, Ph.D., Dorothy Hung, Ph.D., M.A., MPH, both with PAMFRI, and Esther Wei, Sc.D., with the California Pacific Medical Center Research Institute.
Principal Investigator
Funder
Tobacco-Related Disease Research Program (University of California)
Research Topics
Related Studies
Cancer Liquid Biopsy Monitoring Study
Investigators: Deepti Behl, MD, Mohammed Kashani-Sabet, M.D.
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Su-Ying Liang, Ph.D., Cheryl Stults, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigator: Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator, Monique de Bruin, M.D., MPH
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS